Vascular stiffening in aging females with a hypertension‐induced HIF2A gain‐of‐function mutation

Abstract Pulmonary arterial hypertension (PAH) is more prevalent in females than males; the causes of this sex difference have not been adequately explored. Gain‐of‐function (GOF) mutations in hypoxia‐inducible factor 2α (HIF2A) lead to PAH and thrombotic consequences in patients and mice. Additiona...

Full description

Bibliographic Details
Main Authors: Eugenia Volkova, Linda Procell, Lingyang Kong, Lakshmi Santhanam, Sharon Gerecht
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Bioengineering & Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/btm2.10403
_version_ 1797870921808084992
author Eugenia Volkova
Linda Procell
Lingyang Kong
Lakshmi Santhanam
Sharon Gerecht
author_facet Eugenia Volkova
Linda Procell
Lingyang Kong
Lakshmi Santhanam
Sharon Gerecht
author_sort Eugenia Volkova
collection DOAJ
description Abstract Pulmonary arterial hypertension (PAH) is more prevalent in females than males; the causes of this sex difference have not been adequately explored. Gain‐of‐function (GOF) mutations in hypoxia‐inducible factor 2α (HIF2A) lead to PAH and thrombotic consequences in patients and mice. Additionally, multiple emerging studies suggest that elevated systemic arterial stiffening (SAS) occurs in PAH; this could have critical prognostic value. Here, we utilized a HIF2A GOF mouse model to determine how SAS can be used as a prognosticator in sex‐divergent PAH. We analyzed survival, vascular mechanics, and vascular phenotypes in young adult (8–16 weeks) and middle age (9–12 months) Hif2a GOF mice. We find that Hif2a heterozygous (HT) female mice, but not Hif2a HT male mice, exhibit poor survival, SAS upon aging, and decreased ability to withstand repeated physiological strain. Hif2a HT female mice also display thickening of the adventitial intima and increased collagen I and collagen III in all layers of the thoracic aorta. Our findings demonstrate differing PAH progression in female and male Hif2a GOF mice. Specifically, alterations in extracellular matrix (ECM) content led to vascular stiffening in aged females, resulting in poor survival. Moreover, we show that SAS emerges early in mice with PAH by coupling studies of vascular mechanics and analyzing vascular structure and composition. Importantly, we present a model for assessing sex differences in hereditary PAH progression and sex‐specific prognosis, proposing that aortic stiffening can be used to prognosticate future poor outcomes in PAH.
first_indexed 2024-04-10T00:36:06Z
format Article
id doaj.art-31d97831abae4b3caf2516ac6c24b8fb
institution Directory Open Access Journal
issn 2380-6761
language English
last_indexed 2024-04-10T00:36:06Z
publishDate 2023-03-01
publisher Wiley
record_format Article
series Bioengineering & Translational Medicine
spelling doaj.art-31d97831abae4b3caf2516ac6c24b8fb2023-03-14T16:53:48ZengWileyBioengineering & Translational Medicine2380-67612023-03-0182n/an/a10.1002/btm2.10403Vascular stiffening in aging females with a hypertension‐induced HIF2A gain‐of‐function mutationEugenia Volkova0Linda Procell1Lingyang Kong2Lakshmi Santhanam3Sharon Gerecht4Department of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USADepartment of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USADepartment of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USADepartment of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USADepartment of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USAAbstract Pulmonary arterial hypertension (PAH) is more prevalent in females than males; the causes of this sex difference have not been adequately explored. Gain‐of‐function (GOF) mutations in hypoxia‐inducible factor 2α (HIF2A) lead to PAH and thrombotic consequences in patients and mice. Additionally, multiple emerging studies suggest that elevated systemic arterial stiffening (SAS) occurs in PAH; this could have critical prognostic value. Here, we utilized a HIF2A GOF mouse model to determine how SAS can be used as a prognosticator in sex‐divergent PAH. We analyzed survival, vascular mechanics, and vascular phenotypes in young adult (8–16 weeks) and middle age (9–12 months) Hif2a GOF mice. We find that Hif2a heterozygous (HT) female mice, but not Hif2a HT male mice, exhibit poor survival, SAS upon aging, and decreased ability to withstand repeated physiological strain. Hif2a HT female mice also display thickening of the adventitial intima and increased collagen I and collagen III in all layers of the thoracic aorta. Our findings demonstrate differing PAH progression in female and male Hif2a GOF mice. Specifically, alterations in extracellular matrix (ECM) content led to vascular stiffening in aged females, resulting in poor survival. Moreover, we show that SAS emerges early in mice with PAH by coupling studies of vascular mechanics and analyzing vascular structure and composition. Importantly, we present a model for assessing sex differences in hereditary PAH progression and sex‐specific prognosis, proposing that aortic stiffening can be used to prognosticate future poor outcomes in PAH.https://doi.org/10.1002/btm2.10403Arterial StiffeningExtracellular MatrixHIFHIF2aHypertensionHypoxia
spellingShingle Eugenia Volkova
Linda Procell
Lingyang Kong
Lakshmi Santhanam
Sharon Gerecht
Vascular stiffening in aging females with a hypertension‐induced HIF2A gain‐of‐function mutation
Bioengineering & Translational Medicine
Arterial Stiffening
Extracellular Matrix
HIF
HIF2a
Hypertension
Hypoxia
title Vascular stiffening in aging females with a hypertension‐induced HIF2A gain‐of‐function mutation
title_full Vascular stiffening in aging females with a hypertension‐induced HIF2A gain‐of‐function mutation
title_fullStr Vascular stiffening in aging females with a hypertension‐induced HIF2A gain‐of‐function mutation
title_full_unstemmed Vascular stiffening in aging females with a hypertension‐induced HIF2A gain‐of‐function mutation
title_short Vascular stiffening in aging females with a hypertension‐induced HIF2A gain‐of‐function mutation
title_sort vascular stiffening in aging females with a hypertension induced hif2a gain of function mutation
topic Arterial Stiffening
Extracellular Matrix
HIF
HIF2a
Hypertension
Hypoxia
url https://doi.org/10.1002/btm2.10403
work_keys_str_mv AT eugeniavolkova vascularstiffeninginagingfemaleswithahypertensioninducedhif2againoffunctionmutation
AT lindaprocell vascularstiffeninginagingfemaleswithahypertensioninducedhif2againoffunctionmutation
AT lingyangkong vascularstiffeninginagingfemaleswithahypertensioninducedhif2againoffunctionmutation
AT lakshmisanthanam vascularstiffeninginagingfemaleswithahypertensioninducedhif2againoffunctionmutation
AT sharongerecht vascularstiffeninginagingfemaleswithahypertensioninducedhif2againoffunctionmutation